AstraZeneca

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed. 

CEO
Pascal Soriot
CEOPascal Soriot
Employees
94,300
Employees94,300
Headquarters
Cambridge, Cambridgeshire
HeadquartersCambridge, Cambridgeshire
Founded
1913
Founded1913
Employees
94,300
Employees94,300

AZN Key Statistics

Market cap
254.63B
Market cap254.63B
Price-Earnings ratio
29.87
Price-Earnings ratio29.87
Dividend yield
1.91%
Dividend yield1.91%
Average volume
3.58M
Average volume3.58M
High today
$82.19
High today$82.19
Low today
$80.74
Low today$80.74
Open price
$80.95
Open price$80.95
Volume
4.20M
Volume4.20M
52 Week high
$87.25
52 Week high$87.25
52 Week low
$61.24
52 Week low$61.24

AZN News

TipRanks 4h
Personalis reports data from AstraZeneca phase 3 clinical trial in lung cancer

Personalis (PSNL) announced new data from an AstraZeneca (AZN) phase 3 clinical trial in lung cancer. The findings demonstrate that Personalis’ highly sensitive...

TipRanks 8h
AstraZeneca’s Tozorakimab Study: A Potential Game-Changer for COPD Treatment

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

TipRanks 8h
AstraZeneca’s Observational Study on aHUS in China: Key Insights for Investors

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

Analyst ratings

83%

of 30 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

More AZN News

TipRanks 8h
AstraZeneca’s Phase III Study on AZD0780: A Potential Game-Changer in Cardiovascular Treatment

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock...

TipRanks 8h
AstraZeneca’s PRIMULA Lac Study: A Key Update for Anifrolumab Users

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

TipRanks 8h
AstraZeneca’s Real-World Study of Koselugo: Key Insights for Investors

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

TipRanks 8h
AstraZeneca’s COPD Study: Potential Market Shifts Ahead

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

TipRanks 8h
AstraZeneca’s Anifrolumab: A Promising SLE Treatment for Pediatric Patients

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

TipRanks 8h
AstraZeneca’s Innovative Approach to Advanced Gastric Cancer: A Study Update

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

TipRanks 8h
AstraZeneca’s REBECCA Study: Real-World Insights into Early Breast Cancer Management

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.